Pursuant to Regulation 32 of SEBI LODR, Regulations, 2015, we hereby declare that there is no deviation from the purpose stated in offer document in fund raise from conversion of warrants ....

Date: August 12, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001. Scrip Code: 537326 Respected Sir/Ma’am, Subject: Statement on Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations). Pursuant to the provisions of Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Proceeds raised through the conversion of Warrants into Equity Shares pursuant to Preferential Issue for the Quarter ended June 30, 2026 were used for the purpose stated in the offer document and further there is no material deviation. In this regard, please find enclosed herewith Statement in the prescribed format, indicating no deviation or variation in the use of proceeds from conversion of warrants. The aforementioned statement has been reviewed and noted by the Audit Committee at its Meeting held on August 12, 2026. You are requested to take the same on your record. FOR CHEMTECH INDUSTRIAL VALVES LIMITED AAROHI PAREEK COMPANY SECRETARY & COMPLIANCE OFFICER Enclosed: a/a STATEMENT ON DEVIATION OR VARIATION FOR PROCEEDS OF PREFERENTIAL ISSUE Statement on deviation / variation in utilisation of funds raised Name of listed entity Chemtech Industrial Valves Limited Mode of Fund Raising Public Issues / Rights Issues / Preferential Issues / QIP / Others Date of Raising Funds March 27, 2026 Amount Raised 7,50,00,000 Report filed for Quarter ended June 30, 2026 Monitoring Agency NA Monitoring Agency Name, if applicable NA Is there a Deviation / Variation in use of funds raised No If yes, whether the same is pursuant to change in terms NA of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval NA Explanation for the Deviation / Variation NA Comments of the Audit Committee after review None Comments of the auditors, if any None Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Original Modified Funds Amount of Remarks if any Object, if Allocation allocation, Utilised Deviation/Variation any if any for the quarter according to applicable object During Q4 FY 2025-26, 5,00,000 warrants were converted into equity shares at ₹200 per share (₹10 face value and ₹190 securities premium) of long term funding the total consideration, for capital 25% had been received expenditure, NA Rs.57,25,00,000/- No Rs.20,50,00,000/- No at the time of issuance of working capital, the warrants, while the general corporate balance 75%, amounting purposes, etc. to ₹7.50 crore, was received upon conversion on 27 March 2026. The aggregate amount of ₹57.25 crore includes proceeds received earlier during Fund raise via allotment of Equity shares on Preferential mode Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.